NCT02273505View on ClinicalTrials.gov

Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

May 31, 2000

Conditions
Healthy
Interventions
DRUG

Asasantin (ER)

DRUG

Persantin

DRUG

Acetyl salicylic acid (ASA)

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02273505 - Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects | Biotech Hunter | Biotech Hunter